Literature DB >> 3501222

Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics.

J F Kurtzke1, K Hyllested.   

Abstract

Among 32 resident Faroese, clinical MS began between 1943 and 1973 and comprised 3 epidemics, each one significantly later in time and lower in incidence than the preceding. This is confirmed by the present division of the cases of the epidemics according to the calendar time when the patients attained age 11. The risk of MS for Faroese of Epidemic I, (those who acquired the disease from asymptomatic British troops in the World War II occupation), was 18 per 10,000. Depending on the minimum population number required for transmission, the MS risk for Epidemic II was 15 per 18 per 10,000, and for Epidemic III (under our second model) 9 or 11 per 10,000, none differing significantly from Epidemic I. We conclude that the primary MS affection (PMSA) is a single, widespread, specific, systemic infectious disease whose acquisition in virgin populations follows 2 years of exposure starting between age 11 and 45, which then produces clinical neurologic MS (CNMS) in only a small proportion of the affected after an incubation period of 6 (virgin populace) or 12 (endemic areas) years, and which is transmissible only during part or all of this systemic PMSA phase that ends by age 27 or younger.

Entities:  

Mesh:

Year:  1987        PMID: 3501222     DOI: 10.1111/j.1600-0404.1987.tb03590.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

2.  New perspectives in multiple sclerosis.

Authors:  D W Paty
Journal:  Can Fam Physician       Date:  1989-10       Impact factor: 3.275

3.  Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.

Authors:  G Sharpe; S E Price; A Last; R J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

Review 4.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Multiple sclerosis in Northern Ireland: a historical and global perspective.

Authors:  G V McDonnell; S A Hawkins
Journal:  Ulster Med J       Date:  2000-11

6.  Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls.

Authors:  J F Kurtzke; K Hyllested; J D Arbuckle; H Brønnum-Hansen; M T Wallin; A Heltberg; H Jacobsen; A Olsen; L S Eriksen
Journal:  Acta Neurol Scand       Date:  1997-09       Impact factor: 3.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.